Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$35,259,646
+$10,278,693 QoQ
Shares Held
29,397
+8.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.69%
of 13F equity value
Holder Rank
#649
of 4,605 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hemenway Trust Co LLC holds $85,572,547 across 8 Drug Manufacturers - General names. LLY ranks #2 (41.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
166,020 | $42,164,099 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
29,397 | $35,259,646 | |
| 3 | ABBV |
AbbVie Inc.
|
22,641 | $5,697,381 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,860 | $881,510 | |
| 5 | NVS |
Novartis AG
|
3,700 | $579,864 | |
| 6 | NVO |
Novo Nordisk A S
|
8,774 | $420,625 | |
| 7 | AMGN |
Amgen Inc
|
841 | $304,542 | |
| 8 | PFE |
Pfizer Inc
|
11,000 | $264,880 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,259,646 | 29,397 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $24,980,953 | 27,160 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $25,875,072 | 24,077 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $13,510,441 | 17,707 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $9,319,281 | 11,955 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $4,695,298 | 5,685 | Shares | Sole | 2025-04-18 | |
| No filing history on record for this holder in this stock. | ||||||